Bilcare Ltd (526853) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 526853 | NSE: | Plastic Products | Small Cap

Bilcare Share Price

80.44 -1.77 -2.15%
as on 05-Dec'25 15:40

Bilcare Ltd (526853) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 526853 | NSE: | Plastic Products | Small Cap

DeciZen - make an informed investing decision on Bilcare

Based on:

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Somewhat Undervalued

3. Price Trend

Bilcare stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
19.77
Market Cap:
193.6 Cr.
52-wk low:
52.4
52-wk high:
116

Is Bilcare Ltd an attractive stock to invest in?

1. Is Bilcare Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Bilcare Ltd is a average quality company.

2. Is Bilcare Ltd undervalued or overvalued?

The key valuation ratios of Bilcare Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

3. Is Bilcare Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Bilcare Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Bilcare:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Bilcare Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % -11.2%-0.6%-3.2%-20.5%-6.4%7.6%6.1%87.5%1.9%2.2%-
Value Creation
Index
-1.8-1.0-1.2-2.5-1.5-0.5-0.65.3-0.9-0.8-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 3152862582402123044301417.615.111
Sales YoY Gr.--9.5%-9.8%-6.9%-11.7%43.6%41.3%-96.8%25.9%-14.1%-
Adj EPS -29.7-49-106.7-133.3-50-9.8-19.514.5-2.60.94.2
YoY Gr.-NANANANANANANA-118%NA-
BVPS (₹) 264.4236.3202.468.625.125.818.4174.3176.5178.2180.2
Adj Net
Profit
-69.8-115-251-314-118-23.1-45.834.2-6.12.210
Cash Flow from Ops. 28.437.37.262.171.1-0.446.339732.82.4-
Debt/CF from Ops. 34.324.1119.41410-1642.714.900.34.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -28.7%-41%-67.2%-14.1%
Adj EPS NANANANA
BVPS-4.3%48%113%1%
Share Price 2.9% 12.1% 28.4% 42.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
-10.8-19.6-48.6-98.4-106.7-38.6-8815.1-1.50.52.3
Op. Profit
Mgn %
8.6-10.40.8-2.68.38.6-37.2-51.3-37.5-42.7
Net Profit
Mgn %
-22.1-40.4-97.5-130.9-55.6-7.6-10.7244.8-34.914.585.9
Debt to
Equity
1.61.61.85.41211.215.90000
Working Cap
Days
4482782903003462732295,5221,8268371,487
Cash Conv.
Cycle
1406164533640521,07993621,176

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to 2.30%

Sales growth has been subdued in last 3 years -67.23%

Sales growth is not so good in last 4 quarters at -31.95%

Latest Financials - Bilcare Ltd.

Standalone Consolidated
TTM EPS (₹) 4.2 -5.4
TTM Sales (₹ Cr.) 11.4 757
BVPS (₹.) 180.2 192.5
Reserves (₹ Cr.) 401 430
P/BV 0.46 0.43
PE 19.77 0.00
From the Market
52 Week Low / High (₹) 52.35 / 116.00
All Time Low / High (₹) 5.00 / 1830.00
Market Cap (₹ Cr.) 194
Equity (₹ Cr.) 23.6
Face Value (₹) 10
Industry PE 38.6

Management X-Ray of Bilcare:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *1.391.391.391.391.391.391.391.391.391.39
* Pledged shares as % of Promoter's holding (%)

Valuation of Bilcare - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Bilcare

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales315286258240212304430141815
Operating Expenses 300288258240219279393212721
Manufacturing Costs13212122213036131
Material Costs2222121831691431902885105
Employee Cost 27292929273234665
Other Costs 392725202827359810
Operating Profit 15-3-0-0-82537-7-9-6
Operating Profit Margin (%) 4.8%-1.0%-0.1%-0.0%-3.6%8.3%8.5%-51.1%-51.8%-37.5%
Other Income 1151471414164918
Interest 32485672697568024
Depreciation 10179304248883535523
Exceptional Items -117682460245227511110
Profit Before Tax -223-56-101-314-127-18-2450365
Tax -14510-211-24-19-611201
Profit After Tax -78-66-80-315-1022-1839154
PAT Margin (%) -24.8%-23.1%-31.0%-131.0%-48.3%0.6%-4.1%2,794.6%30.3%26.4%
Adjusted EPS (₹)-33.2-28.0-34.0-133.0-43.50.8-7.6166.02.31.7
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 623556477161596143410416420
Share Capital 24242424242424242424
Reserves 599533453138363720387392396
Minority Interest0000000000
Debt9768988578687096786908910
Long Term Debt7737147027145595305378910
Short Term Debt203184155153150149153000
Trade Payables47505772516179622
Others Liabilities 34242616521369243363422
Total Liabilities 1,9881,9311,5551,314887823816460461453

Fixed Assets

Gross Block1,5681,5871,5871,5851,586901909317876
Accumulated Depreciation3924407439911,079429463151416
Net Fixed Assets 1,1771,147844594506473446166361
CWIP 0000000000
Investments 5535535145131738981294294294
Inventories52302532224456110
Trade Receivables60494137397293953
Cash Equivalents 116375851223
Others Assets 1351461281311411361361289792
Total Assets 1,9881,9311,5551,314887823816460461453

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 283776271-046397332
PBT -223-124-346-314-151-70-51-8-55
Adjustment 25212828632135213693390117
Changes in Working Capital -0356956-130-6851726-11
Tax Paid -0-1-1-1-11-1-111
Cash Flow From Investing Activity 9-4878211856181-423
Capex -0-50-11-01-1394-433
Net Investments 801111847-213-00
Others 11780000010
Cash Flow From Financing Activity -356-87-60-83-82-55-571-1-4
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000020
Interest Paid 0-48-56-72-69-75-68-0-2-4
Dividend Paid 0000000000
Others -3554-3112-14-813-570-0-0
Net Cash Flow 2-5-13-12-47-101

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)-12.13-11.18-15.48-98.82-92.772.98-34.16172.221.290.96
ROCE (%)-11.22-0.56-3.23-20.49-6.47.586.0687.451.942.18
Asset Turnover Ratio0.150.160.150.170.190.360.520.020.040.03
PAT to CFO Conversion(x)N/AN/AN/AN/AN/A-0N/A1.026.60.5
Working Capital Days
Receivable Days726462596667701,332149100
Inventory Days1054838444640437451411
Payable Days6084107140156107883,116154164

Bilcare Ltd Stock News

Bilcare Ltd FAQs

The current trading price of Bilcare on 05-Dec-2025 15:40 is ₹80.44.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Bilcare stood at ₹193.6.
The latest P/E ratio of Bilcare as of 04-Dec-2025 is 19.77.
The latest P/B ratio of Bilcare as of 04-Dec-2025 is 0.46.
The 52-week high of Bilcare is ₹116.0 and the 52-week low is ₹52.35.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Bilcare is ₹11.41 ( Cr.) .

About Bilcare Ltd

Bilcare, incorporated in the year 1987, is engaged in manufacturing pharmaceutical packaging. It has an experience of working with 500 pharma manufacturing companies worldwide.Bilcare is a global leader and an innovation-led packaging solutions provider that partners with the pharmaceutical industry to improve patient healthcare outcomes. The company endeavor to deliver effective and affordable solutions that enhance the speed and quality of drug discovery and help build and protect brands by ensuring the delivery of genuine medicines to patients.

Bilcare PPI offers Innovative Pharmaceutical Packaging Solutions comprising of a wide range of specialty Polymer Films and Aluminum Foils mainly used for packaging of solid dosage pharmaceutical products.

Bilcare GCS provides Global Clinical Material Supplies for new drug discovery projects.

Bilcare Technologies provides Anti-counterfeit (ncID - nonclonableID) solutions for product & people ID authentication and security
The company develops design keeping various aspects into consideration such as end-user, optimum material, composite dosages, on-pack communication, cost-effective, regulatory requirements, etc.It also offers pharmaceutical research and clinical services.

It has representative offices located in Argentina, Bangladesh, Chile, Colombia, Czech Republic, Egypt, France, Indonesia, Iran, Israel, Italy, Jordan, South Korea, Malaysia, Mexico, Pakistan, Saudi Arabia, South Africa, Spain, Taiwan, Thailand, Turkey, Venezuela and Vietnam.

It maintains quality standards prescribed by various agency such USFDA, DEA, IQA, SAP, ISO 9001 and 14001.Bilcare has a global customer base and customers comprise many of the largest global pharmaceutical companies viz. Bristol-Myers Squibb, Dr. Reddy’s, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Ranbaxy, Sanofi-Aventis, Teva to name a few. Bilcare has a strong customer base of over 2,500 customers in over 50 countries worldwide.

For packaging purposes the company uses material like blister films range, aluminium foils, cold formed blisters, wrap systems, closures & containers, flexibles and eco-friendly paper composites.

Bilcare Singapore Pte a wholly owned subsidiary acquired 100 percent stakes in Singapore-based Singular ID. The firm specialises in technology to identify fake drugs.

In 2010 Bilcare won Pharmexcil / Govt of India Patent Award-2009-10.

You have 0 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×